Since SGLT2 inhibitors reduced ROS formation in endothelial cells46, such an effect may also prevent the oxidative degradation of NO, thus alleviating NPs-induced NADPH-dependent oxidative stress, ECs senescence and endothelial dysfunction. The gene discussed is DECR1; the disease is endothelial dysfunction.